About this Research Topic
The field of proteomics is also instrumental in identifying new drug targets. Proteomics allows the identification and quantification of proteins present in cells or tissues, providing insights into the functional changes occurring in cancer, The identification of specific proteins that are dysregulated in cancer can lead to the development of targeted therapies aimed at restoring normal protein function or inhibiting aberrant protein activity. Metabolomics, the study of small molecules, plays a significant role in discovering new drug targets for cancer therapy. Metabolomic analysis can detect alterations in the metabolic profile of cancer cells, providing insight into the metabolic dependencies that drive tumor growth. Identifying specific metabolic pathways that are crucial for cancer cell survival opens up new opportunities for developing drugs that selectively target these pathways.
The integration of these omics approaches, along with bioinformatics and computational analysis, has dramatically accelerated the discovery of new drug targets for cancer therapy. This special issue aims to showcase the cutting-edge research utilizing these strategies to identify novel drug targets and advance cancer treatment options.
This special issue aims to highlight the latest advancements in utilizing omics strategies to discover new drug targets for various types of cancers.
Keywords: Omics, new drugs, cancer, precision medicine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.